Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis

• Status: Completed
• Trial end date: 2021-04-06
• Target enrollment: 0
• Participant gender: All

Summary

Patients having juvenile idiopathic arthritis (according to ILAR criteria) with hip arthritis were divided into two groups. Group 1 received hip denervation and group 2 controlled and received a subcutaneous injection of saline. Outcome measures included pain, tenderness, range of motion, range of motion, HARISS score. These outcomes were measured at baseline, 2 weeks, and 12 weeks

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sohag University
• Treatments: Bupivacaine; Lidocaine

Criteria

Inclusion Criteria:

• patients with JIA with unilateral hip arthritis

Exclusion Criteria:

• hip involvement due to other causes including

• septic arthritis

• other connective tissue diseases

• Avascular necrosis